Michael Klichinsky, Chief Scientific Officer of Carisma Therapeutics Inc. ($CARM), made four open market sales of common shares over the last year, totaling about $139,000. His most recent sale occurred on October 7, 2025. These insider sales rank 9,100th among 11,678 individuals in the database, well below the average of $8.6 million per insider across 6.4 transactions. Klichinsky made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 7, 2025 | Carisma Therapeutics Inc. | $CARM | Klichinsky Michael | Chief Scientific Officer | M | Common Stock | 56982 | $0.11 | 56,982.0000 | 41,788,096 | 9999.99% | 0.14% |
| Oct. 7, 2025 | Carisma Therapeutics Inc. | $CARM | Klichinsky Michael | Chief Scientific Officer | M | Stock Option (right to buy) | 56982 | $0.00 | 0.0000 | 41,788,096 | 100.00% | 0.14% |
| Oct. 7, 2025 | Carisma Therapeutics Inc. | $CARM | Klichinsky Michael | Chief Scientific Officer | S | Common Stock | 56982 | $0.25 | 0.0000 | 41,788,096 | 100.00% | 0.14% |
| Oct. 1, 2025 | Carisma Therapeutics Inc. | $CARM | Klichinsky Michael | Chief Scientific Officer | S | Common Stock | 165000 | $0.26 | 319,347.0000 | 41,788,096 | 34.07% | 0.39% |
| Oct. 2, 2025 | Carisma Therapeutics Inc. | $CARM | Klichinsky Michael | Chief Scientific Officer | S | Common Stock | 200000 | $0.25 | 119,347.0000 | 41,788,096 | 62.63% | 0.48% |
| Oct. 3, 2025 | Carisma Therapeutics Inc. | $CARM | Klichinsky Michael | Chief Scientific Officer | S | Common Stock | 119347 | $0.26 | 0.0000 | 41,788,096 | 100.00% | 0.29% |
| Jan. 28, 2025 | Carisma Therapeutics Inc. | $CARM | Klichinsky Michael | Chief Scientific Officer | A | Stock Option (Right to Buy) | 221000 | $0.00 | 221,000.0000 | 0 | 9999.99% | 0.00% |
| June 17, 2024 | Carisma Therapeutics Inc. | $CARM | Klichinsky Michael | Chief Scientific Officer | A | Stock Option (Right to Buy) | 85000 | $0.00 | 85,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Carisma Therapeutics Inc. | $CARM | Klichinsky Michael | Chief Scientific Officer | A | Stock Option (Right to Buy) | 170500 | $0.00 | 170,500.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | Carisma Therapeutics Inc. | $CARM | Klichinsky Michael | Chief Scientific Officer | A | Stock Option (Right to Buy) | 238000 | $0.00 | 238,000.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2023 | Carisma Therapeutics Inc. | $CARM | Klichinsky Michael | Chief Scientific Officer | A | Stock Option (Right to Buy) | 112064 | $0.00 | 112,064.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2023 | Carisma Therapeutics Inc. | $CARM | Klichinsky Michael | Chief Scientific Officer | A | Common Stock | 484347 | $0.00 | 484,347.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2023 | Carisma Therapeutics Inc. | $CARM | Klichinsky Michael | Chief Scientific Officer | A | Stock Option (Right to Buy) | 56982 | $0.00 | 56,982.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2023 | Carisma Therapeutics Inc. | $CARM | Klichinsky Michael | Chief Scientific Officer | A | Stock Option (Right to Buy) | 75976 | $0.00 | 75,976.0000 | 0 | 9999.99% | 0.00% |